News

A dedicated interventional cardiology track is slated during the 2006 Scientific Sessions of the AHA in Chicago that ...

Home November 05, 2006
Home
News

The FDA has approved NitroMist (Nitroglycerin Lingual Aerosol) for acute relief of an attack or acute prophylaxis of ...

Home November 05, 2006
Home
News

Washington University surgeons at Barnes-Jewish Hospital, St. Louis, began training at UMC in Tucson on Nov. 2 to become ...

Home November 05, 2006
Home
News

Results from the Phase II MEND-CABG study — which looked at demonstrated the clinical benefits of MC-1 in reducing ...

Home November 05, 2006
Home
News

A new study published in the Oct. 30 edition of “Circulation” calls the onset of peripheral arterial disease (PAD) among ...

Home November 05, 2006
Home
News

NewYork-Presbyterian Hospital now offers a new alternative therapy for heart failure patients at risk for sudden cardiac ...

Home November 02, 2006
Home
News

Boston Scientific has launched new software enabling its Left Ventricular (LV) Offset feature in the CONTAK RENEWAL ...

Home November 02, 2006
Home
News

Well-known cardiologist Eric Topol has been appointed by Scripps Health in San Diego, CA, to lead a new institute to ...

Home November 02, 2006
Home
News

A new cooling pad enters the healthcare market, joining a growing number of cooling systems used to induce hypothermia ...

Home November 02, 2006
Home
News

A new alternative to invasive, painful biopsies for determining heart transplant rejection is both available and ...

Home November 02, 2006
Home
News

November 2006 - Physicians at UT Southwestern Medical Center are part of a multinational clinical trial evaluating the Optimizer System, a unique implantable device designed to treat a larger number of patients with heart failure. UT Southwestern is one of the top enrolling centers of the 50 sites in the U.S.

Home November 02, 2006
Home
News

The Certification Commission for Healthcare Information Technology is inviting organizations to submit their ambulatory ...

Home November 01, 2006
Home
News

Results from the Danish SORT-OUT II study, the largest randomized trial to date comparing Taxus and Cypher drug-eluting ...

Home November 01, 2006
Home
News

Healthcare IT companies will again converge this winter to measure their ability to integrate with each other during the ...

Home November 01, 2006
Home
News

A large California-based study has shown that patients with heart failure who start taking statins, compared with those who don't, will live longer and have a lower hospitalization risk regardless of cholesterol levels, presence or absence of coronary disease, and other CV drug therapies, “Heartwire” reported this week.

Home November 01, 2006
Home
Subscribe Now